Martell RON
SEC-identified person · CIK 1177079 Identifier-verified
Public-company roles (from insider filings)
| Company | Capacity as filed | Filings |
|---|---|---|
| Jasper Therapeutics, Inc. JSPR | Director · President, CEO and Director | filed 2022–2026 |
| Plus Therapeutics, INC. PSTV | Director | filed 2017–2017 |
| Kalobios Pharmaceuticals INC KBIOQ | Director · Executive Chairman | filed 2015–2015 |
| Sevion Therapeutics, Inc. SVOND | Director · Chief Executive Officer | filed 2014–2014 |
| Neurogesx Inc NGSX | Director · President and CEO | filed 2012–2013 |
| Poniard Pharmaceuticals, INC. PARD | Director · President & COO | filed 2006–2011 |
| Imclone Systems INC/DE IMCL | SVP, Commercial Operations | filed 2006–2006 |
All roles under one Commission-assigned identifier - the same person by the SEC's own record, not by name matching. From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.